RT3
Retatrutide-10mg, 20mg, 30mg
Triple hormone receptor research (GLP-1, GIP, and glucagon) targeting insulin regulation, blood sugar control, and metabolic balance.
Retatrutide
A long-acting triple receptor agonist that activates the GLP-1, GIP, and glucagon receptors, designed to study how simultaneous incretin and glucagon pathway stimulation influences metabolism, appetite regulation, and energy balance.
Research Focus
-
Mechanisms of glucose control, insulin secretion, and metabolic adaptation.
-
Regulation of appetite, fat oxidation, and body composition.
-
Coordination between pancreatic, hepatic, and central nervous system signaling.
-
Comparison of triple vs. dual-pathway metabolic effects.
-
Investigation into obesity, insulin resistance, and cardio-metabolic function.
Mechanisms Under Study
-
Combined activation of GLP-1, GIP, and glucagon receptors.
-
Integration of hormonal feedback loops governing nutrient sensing and energy use.
-
Enhancement of lipid metabolism and lean mass preservation under metabolic stress.
Product Information
-
Supplied as a lyophilized sterile powder.
-
Third-party verified for purity, molecular identity, and composition.
-
For laboratory research use only, not for human or animal use.
